{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:21:35Z","timestamp":1761862895896},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2010,3,12]],"date-time":"2010-03-12T00:00:00Z","timestamp":1268352000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2010,8]]},"DOI":"10.1007\/s10157-010-0273-4","type":"journal-article","created":{"date-parts":[[2010,3,11]],"date-time":"2010-03-11T08:31:13Z","timestamp":1268296273000},"page":"367-371","source":"Crossref","is-referenced-by-count":15,"title":["Minimal change nephrotic syndrome in a patient with strongyloidiasis"],"prefix":"10.1007","volume":"14","author":[{"given":"Mieko","family":"Miyazaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahito","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narutoshi","family":"Kabashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Serino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tatsuya","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsu","family":"Miyamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumi","family":"Furuno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuo","family":"Nishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiro","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Otsuji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,12]]},"reference":[{"key":"273_CR1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jinf.2006.01.016","volume":"54","author":"L Fardet","year":"2007","unstructured":"Fardet L, Genereau T, Poirot JL, Guidet B, Kettaneh A, Cabane J. Severe strongyloidiasis in corticosteroid-treated patients: case series and literature review. J Infect. 2007;54:18\u201327.","journal-title":"J Infect"},{"key":"273_CR2","doi-asserted-by":"crossref","unstructured":"Saito A. Strongyloidiasis\u2014progress in its diagnosis and treatment. Nippon Naika Gakkai Zasshi. 2003;92:399\u2013403.","DOI":"10.2169\/naika.92.399"},{"key":"273_CR3","doi-asserted-by":"crossref","first-page":"459","DOI":"10.5414\/CNP66459","volume":"66","author":"YP Hsieh","year":"2006","unstructured":"Hsieh YP, Wen YK, Chen ML. Minimal change nephrotic syndrome in association with strongyloidiasis. Clin Nephrol. 2006;66:459\u201363.","journal-title":"Clin Nephrol"},{"key":"273_CR4","first-page":"398","volume":"57","author":"J Morimoto","year":"2002","unstructured":"Morimoto J, Kaneoka H, Sasatomi Y, Sato YN, Murata T, Ogahara S, et al. Disseminated strongyloidiasis in nephrotic syndrome. Clin Nephrol. 2002;57:398\u2013401.","journal-title":"Clin Nephrol"},{"key":"273_CR5","first-page":"221","volume":"52","author":"PA Sathe","year":"2006","unstructured":"Sathe PA, Madiwale CV. Strongyloidiasis hyperinfection in a patient with membranoproliferative glomerulonephritis. J Postgrad Med. 2006;52:221\u20132.","journal-title":"J Postgrad Med"},{"key":"273_CR6","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s10096-005-0070-2","volume":"25","author":"CS Lam","year":"2006","unstructured":"Lam CS, Tong MK, Chan KM, Siu YP. Disseminated strongyloidiasis: a retrospective study of clinical course and outcome. Eur J Clin Microbiol Infect Dis. 2006;25:14\u20138.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"273_CR7","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/CDLI.12.5.680-682.2005","volume":"12","author":"RC Seet","year":"2005","unstructured":"Seet RC, Lau LG, Tambyah PA. Strongyloides hyperinfection and hypogammaglobulinemia. Clin Diagn Lab Immunol. 2005;12:680\u20132.","journal-title":"Clin Diagn Lab Immunol"},{"key":"273_CR8","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3143\/geriatrics.40.397","volume":"40","author":"M Mitsunaga","year":"2003","unstructured":"Mitsunaga M, Miyauchi N, Akiyama Y, Saima S. A case of strongyloidiasis hyperinfection during oral corticosteroid therapy associated with a nephrotic patient infected with HTLV-1. Nippon Ronen Igakkai Zasshi. 2003;40:397\u2013401.","journal-title":"Nippon Ronen Igakkai Zasshi"},{"key":"273_CR9","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.1016\/S0272-6386(99)80003-1","volume":"33","author":"YK Yee","year":"1999","unstructured":"Yee YK, Lam CS, Yung CY, Que TL, Kwan TH, Au TC, et al. Strongyloidiasis as a possible cause of nephrotic syndrome. Am J Kidney Dis. 1999;33:E4.","journal-title":"Am J Kidney Dis"},{"key":"273_CR10","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1159\/000045058","volume":"79","author":"TY Wong","year":"1998","unstructured":"Wong TY, Szeto CC, Lai FF, Mak CK, Li PK. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents. Nephron. 1998;79:333\u20136.","journal-title":"Nephron"},{"key":"273_CR11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.2169\/internalmedicine.37.606","volume":"37","author":"S Mori","year":"1998","unstructured":"Mori S, Konishi T, Matsuoka K, Deguchi M, Ohta M, Mizuno O, et al. Strongyloidiasis associated with nephrotic syndrome. Intern Med. 1998;37:606\u201310.","journal-title":"Intern Med"},{"key":"273_CR12","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJM196611172752003","volume":"275","author":"T Cruz","year":"1966","unstructured":"Cruz T, Reboucas G, Rocha H. Fatal strongyloidiasis in patients receiving corticosteroids. N Engl J Med. 1966;275:1093\u20136.","journal-title":"N Engl J Med"},{"key":"273_CR13","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(66)90303-5","volume":"1","author":"AJ Willis","year":"1966","unstructured":"Willis AJ, Nwokolo C. Steroid therapy and strongyloidiasis. Lancet. 1966;1:1396\u20138.","journal-title":"Lancet"},{"key":"273_CR14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1476-7961-4-8","volume":"4","author":"RS Vadlamudi","year":"2006","unstructured":"Vadlamudi RS, Chi DS, Krishnaswamy G. Intestinal strongyloidiasis and hyperinfection syndrome. Clin Mol Allergy. 2006;4:8.","journal-title":"Clin Mol Allergy"},{"key":"273_CR15","doi-asserted-by":"crossref","unstructured":"Segarra-Newnham M. Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. Ann Pharmacother. 2007;41:1992\u20132001.","DOI":"10.1345\/aph.1K302"},{"key":"273_CR16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1053\/snep.2003.50008","volume":"23","author":"V Boonpucknavig","year":"2003","unstructured":"Boonpucknavig V, Soontornniyomkij V. Pathology of renal diseases in the tropics. Semin Nephrol. 2003;23:88\u2013106.","journal-title":"Semin Nephrol"},{"key":"273_CR17","doi-asserted-by":"crossref","unstructured":"Simon DI, Brosius FC, Rothstein DM. Sulfadiazine crystalluria revisited. The treatment of toxoplasma encephalitis in patients with acquired immunodeficiency syndrome. Arch Intern Med. 1990;150:2379\u201384.","DOI":"10.1001\/archinte.1990.00390220113023"},{"key":"273_CR18","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s004670050330","volume":"11","author":"PD Thomson","year":"1997","unstructured":"Thomson PD. Renal problems in black South African children. Pediatr Nephrol. 1997;11:508\u201312.","journal-title":"Pediatr Nephrol"},{"key":"273_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jpeds.2009.06.049","volume":"156","author":"L Copelovitch","year":"2010","unstructured":"Copelovitch L, Sam Ol O, Taraquinio S, Chanpheaktra N. Childhood nephrotic syndrome in Cambodia: an association with gastrointestinal parasites. J Pediatr. 2010;156:76\u201381.","journal-title":"J Pediatr"},{"key":"273_CR20","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/jcp.44.3.243","volume":"44","author":"DS Gill","year":"1991","unstructured":"Gill DS, Fonseca VA, Barradas MA, Balliod R, Moorhead JF, Dandona P. Plasma histamine in patients with chronic renal failure and nephrotic syndrome. J Clin Pathol. 1991;44:243\u20135.","journal-title":"J Clin Pathol"},{"key":"273_CR21","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1182\/blood.V96.6.2191","volume":"96","author":"R Bheekha-Escura","year":"2000","unstructured":"Bheekha-Escura R, MacGlashan DW, Langdon JM, MacDonald SM. Human recombinant histamine-releasing factor activates human eosinophils and the eosinophilic cell line, AML14\u20133D10. Blood. 2000;96:2191\u20138.","journal-title":"Blood"},{"key":"273_CR22","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/j.1365-2249.2005.02890.x","volume":"142","author":"S Toyabe","year":"2005","unstructured":"Toyabe S, Kaneko U, Hara M, Uchiyama M. Expression of immunoglobulin E-dependent histamine-releasing factor in idiopathic nephrotic syndrome of childhood. Clin Exp Immunol. 2005;142:162\u20136.","journal-title":"Clin Exp Immunol"},{"key":"273_CR23","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1517\/14656566.5.12.2615","volume":"5","author":"R Igual-Adell","year":"2004","unstructured":"Igual-Adell R, Oltra-Alcaraz C, Soler-Company E, Sanchez-Sanchez P, Matogo-Oyana J, Rodriguez-Calabuig D. Efficacy and safety of ivermectin and thiabendazole in the treatment of strongyloidiasis. Expert Opin Pharmacother. 2004;5:2615\u20139.","journal-title":"Expert Opin Pharmacother"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0273-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-010-0273-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-010-0273-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,2]],"date-time":"2020-06-02T23:31:39Z","timestamp":1591140699000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-010-0273-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,12]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,8]]}},"alternative-id":["273"],"URL":"https:\/\/doi.org\/10.1007\/s10157-010-0273-4","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,12]]}}}